As historians we rarely predict the future since we are trained to look at the past, draw lessons from it, and identify ...
Ibec’s first assessment of current measures projects a loss of between four and six billion euro in trade in the short term.
Percentage of modern pollen taxa of several plant varieties, which plays a crucial role in their reproductive processes, found to be very low, says research ...
Coal-fired power plants in India—responsible for generating 73.4% of the country’s electricity —are bad for the country’s ...
These were developed mainly to treat type 2 diabetes, though they can also be given to treat weight loss. Eli Lilly currently holds the expert committee's permission but the Indian drug regulator ...
US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).
Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...
In India, forests play a crucial role in cultural heritage, economic development, and biodiversity conservation. Recognising their importance, the Ministry of Environment, Forest and Climate ...
Eli Lilly launched Mounjaro, a weight-loss injectable, in India, priced at ₹4,375 for 5 mg, targeting obesity and type-2 diabetes management. American drugmaker Eli Lilly and Company launched ...
A historic day for Indian federalism! I extend my warmest welcome to the leaders from Kerala, Karnataka, Andhra Pradesh, Telangana, Odisha, West Bengal & Punjab who are joining us for the Joint ...
The world unites on Friday to celebrate the International Day of Forests, a day dedicated to recognizing the vital role forests play in sustaining life on Earth. Forests are among the planet’s richest ...
(Image Credits: Pexels) Eli Lilly and Company (India) on Thursday announced the launch of Mounjaro in single-dose vial presentation following the marketing authorization from the Central Drugs ...